Xq28 Duplications and Epilepsy: Influence of the Combinatory Duplication of MECP2 and GDI1

Abstract

Xq28 duplications including the MECP2 (Methyl-CpG-binding protein 2) cause an X-linked recessive neurodegenerative disorder that presents symptoms such as early developmental delay, progressive deterioration, and intractable epilepsy. Submicroscopic interstitial duplication in the MECP2 region is one of the most frequently observed submicroscopic chromosomal aberrations in patients with intellectual disability. This high prevalence is derived from the genomic instability characteristic of this region due to segmental duplications that are densely located in this region, which are prone to cause nonallelic homologous recombination during meiosis. Patients with MECP2 duplications generally begin to show epilepsy after 6 years of age. Therefore, incidence of epilepsy is high in adolescents. Although many types of seizures have been reported in patients, the most frequently observed seizure types were absence seizure and generalized tonic–clonic seizures. Because drop attacks are frequently seen, such epileptic attacks are sometimes life-threatening. We encountered a patient who showed epileptic spasms during infancy with a relatively larger duplication that encompasses MECP2 and GDI1 (GDP dissociation inhibitor-1). This led us to speculate that the combinatory duplication that includes MECP2 and GDI1 may cause severe epileptic features; however, most of the previously reported patients with combined duplications of MECP2 and GDI1 did not showed early occurrence of epilepsy. Therefore, further information would be required to confirm if the combinatory duplication of MECP2 and GDI1 exerts any influence on the severity of epilepsy.

Keywords

Xq28 duplication - epilepsy - intellectual disability - MECP2 - GDI1

• References

• 1 Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999; 23 (2) 185-188
• 2 Philippe C, Villard L, De Roux N , et al. Spectrum and distribution of MECP2 mutations in 424 Rett syndrome patients: a molecular update. Eur J Med Genet 2006; 49 (1) 9-18
• 3 Villard L. MECP2 mutations in males. J Med Genet 2007; 44 (7) 417-423
• 4 Meins M, Lehmann J, Gerresheim F , et al. Submicroscopic duplication in Xq28 causes increased expression of the MECP2 gene in a boy with severe mental retardation and features of Rett syndrome. J Med Genet 2005; 42 (2) e12
• 5 Shimada S, Okamoto N, Ito M , et al. MECP2 duplication syndrome in both genders. Brain Dev 2013; 35 (5) 411-419
• 6 Ramocki MB, Tavyev YJ, Peters SU. The MECP2 duplication syndrome. Am J Med Genet A 2010; 152A (5) 1079-1088
• 7 Yamamoto T, Shimojima K, Shimada S , et al. Clinical impacts of genomic copy number gains at Xq28. Human Genome Variation. Available at: http://www.nature.com/articles/hgv20141 . Accessed September 19, 2014
• 8 Bienvenu T, des Portes V, Saint Martin A , et al. Non-specific X-linked semidominant mental retardation by mutations in a Rab GDP-dissociation inhibitor. Hum Mol Genet 1998; 7 (8) 1311-1315
• 9 Vandewalle J, Van Esch H, Govaerts K , et al. Dosage-dependent severity of the phenotype in patients with mental retardation due to a recurrent copy-number gain at Xq28 mediated by an unusual recombination. Am J Hum Genet 2009; 85 (6) 809-822
• 10 Van Esch H, Bauters M, Ignatius J , et al. Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am J Hum Genet 2005; 77 (3) 442-453
• 11 Friez MJ, Jones JR, Clarkson K , et al. Recurrent infections, hypotonia, and mental retardation caused by duplication of MECP2 and adjacent region in Xq28. Pediatrics 2006; 118 (6) e1687-e1695
• 12 Echenne B, Roubertie A, Lugtenberg D , et al. Neurologic aspects of MECP2 gene duplication in male patients. Pediatr Neurol 2009; 41 (3) 187-191
• 13 Ramocki MB, Peters SU, Tavyev YJ , et al. Autism and other neuropsychiatric symptoms are prevalent in individuals with MeCP2 duplication syndrome. Ann Neurol 2009; 66 (6) 771-782
• 14 Vignoli A, Borgatti R, Peron A , et al. Electroclinical pattern in MECP2 duplication syndrome: eight new reported cases and review of literature. Epilepsia 2012; 53 (7) 1146-1155
• 15 Fukushi D, Yamada K, Nomura N , et al. Clinical characterization and identification of duplication breakpoints in a Japanese family with Xq28 duplication syndrome including MECP2. Am J Med Genet A 2014; 164A (4) 924-933
• 16 Caumes R, Boespflug-Tanguy O, Villeneuve N , et al. Late onset epileptic spasms is frequent in MECP2 gene duplication: electroclinical features and long-term follow-up of 8 epilepsy patients. Eur J Paediatr Neurol 2014; 18 (4) 475-481
• 17 Smyk M, Obersztyn E, Nowakowska B , et al. Different-sized duplications of Xq28, including MECP2, in three males with mental retardation, absent or delayed speech, and recurrent infections. Am J Med Genet B Neuropsychiatr Genet 2008; 147B (6) 799-806
• 18 Clayton-Smith J, Walters S, Hobson E , et al. Xq28 duplication presenting with intestinal and bladder dysfunction and a distinctive facial appearance. Eur J Hum Genet 2009; 17 (4) 434-443
• 19 Lugtenberg D, Kleefstra T, Oudakker AR , et al. Structural variation in Xq28: MECP2 duplications in 1% of patients with unexplained XLMR and in 2% of male patients with severe encephalopathy. Eur J Hum Genet 2009; 17 (4) 444-453
• 20 Reardon W, Donoghue V, Murphy AM , et al. Progressive cerebellar degenerative changes in the severe mental retardation syndrome caused by duplication of MECP2 and adjacent loci on Xq28. Eur J Pediatr 2010; 169 (8) 941-949